- Research note
- Open Access
Serological prevalence and public health significance of brucellosis on a dairy farm in Namibia from 2011 to 2014
BMC Research Notes volume 10, Article number: 620 (2017)
The main objective of this study was to determine the serological prevalence of brucellosis on a dairy farm with no past history of abortions, but where Brucella control measures including test and slaughter and vaccination of heifers at 4–8 months of age was practiced. Secondary data from 2011 to 2014 obtained from the Epidemiology Section of the Directorate of Veterinary Services was used.
Mandatory annual brucellosis testing results for mature dairy cows on a dairy farm for the period 2011–2014 were collated and analyzed. Results of a total of 6912 cows were analysed. The data comprised of the year of testing, number of cows tested for Brucella antibodies and the number of cows that tested positive. Serological testing was carried out using the Rose Bengal Test (RBT) as a screening test and the Complement Fixation Test as a confirmatory test for results that tested positive on the RBPT. Over the 4-year period, one dairy cow tested positive for Brucella antibodies in 2013 giving an apparent prevalence of 0.05% and an overall prevalence of 0.01%. When apparent prevalence was adjusted for RBPT test specificity and sensitivity of 71 and 78% respectively, true prevalence was determined to be zero.
Brucellosis is a zoonosis of major public health, animal welfare and economic significance . It is endemic in most African countries . A number of biovars of Brucella abortus, B. melitensis and B. suis are responsible for the disease in domestic animals  and zoonotic disease. Brucella abortus and B. melitensis are common causes of brucellosis in cattle, sheep and goats respectively . Of the three Brucella species, B. melitensis causes the most severe disease in humans. In Namibia, Brucella melitensis was first reported in Karakul sheep .
Infection in humans is commonly acquired through direct and indirect contact with infected material such as aborted foetuses and the consumption of raw milk and unpasteurised dairy products including soft cheeses . The disease in humans may result in abortions in pregnant women, infertility or a chronic debilitating disease. Available evidence suggests that persons infected with the Human Immunodeficiency Virus (HIV) are at a greater risk of severe brucellosis .
The economic significance of brucellosis results from production losses associated with abortions, mastitis, milk fever, retained placenta, metritis, impaired fertility and arthritis . Milk production losses in infected dairy cows can be up to 20% and the inter-calving period can be prolonged by several months .
In Namibia, brucellosis has been reported in sheep ; sheep and springbok ([8,9,10] and other wild ruminants . However, there is limited information on the prevalence of the disease in dairy cattle that are a source of raw milk to a greater part of the Namibian population. Therefore, this study was carried out to determine the serological prevalence of brucellosis on a dairy farm so as to make inferences about the potential exposure of consumers of raw milk to brucellosis and to provide a basis for future studies on bovine brucellosis.
Study farm and animals
The study farm was located south of the veterinary cordon fence and was one of the two major dairy enterprises in the country with about 2000 dairy cows and heifers. Milk produced from the farm was processed and sold as fresh or pasteurised. Sera for the brucellosis testing program were obtained from sexually mature Friesian–Holstein cows of various ages, at different stages of lactation and reproductive status fed on irrigated pastures. Heifers were not part of the testing program. The numbers of animals on the farm fluctuated each year due to introductions of replacement heifers or the exit of culled cows from the herd.
Data for this retrospective study was obtained from the Epidemiology Section of the Directorate of Veterinary Services with permission of the dairy farm. The data from 2011 to 2014 comprising of the year of testing, number of cows tested for Brucella antibodies and the number of cows that tested positive was collated and analysed using simple descriptive statistics in Microsoft Excel® program to estimate annual and overall brucellosis prevalence.
Testing of sera
Sera were screened for Brucella antibodies using the Rose Bengal Test (RBT). Sera testing positive on the RBT were confirmed using the Complement Fixation Test (CFT) following the procedure described in the OIE Manual . In the RBT test, any agglutination observed was considered as test positive. In the CFT test, if haemolysis was present, the sample was considered negative, and the absence of haemolysis as indicated by a red button in the centre of the well, was considered positive as described by Chisi et al. .
Results of this study are summarised in Table 1. A total of 6912 cows were tested for Brucella antibodies over the 4-year period. One dairy cow tested positive for Brucella antibodies in 2013 with a titre of 1:8 giving an apparent prevalence of 0.05% and no positive reactors were recorded in 2011, 2012 and 2014. Overall prevalence was 0.01%. Apparent prevalence (annual and overall) were adjusted according to Reiczigel et al.  using RBPT test specificity and sensitivity of 71 and 78%  respectively and were found to be zero in both cases.
A total of 6912 Friesian–Holstein cows were tested for brucellosis from 2011 to 2014. These were cows in the same herd that were repeatedly tested for brucellosis every year for 4 years. The number of dairy cows tested per year fluctuated with the number of replacement heifers introduced and cows culled from the herd. Over the 4 year period, one cow tested positive for Brucella antibodies in the year 2013 giving a low annual and overall apparent prevalence of 0.05 and 0.01% respectively. True prevalence calculated by adjusting apparent prevalence for RBT test sensitivity and specificity according to Reiczigel et al.  was determined to be zero indicating that the positive test may have been a false positive. Cross reactions with other organisms such Yersinia enterocolitica O:9 [16,17,18] and the vaccination of heifers between 4 and 8 months of age could have been responsible for the positive reactor. Heifers were vaccinated using Brucella S19 vaccine at 5 months according to the compulsory vaccination protocol. The S19 vaccine can result in the production of persistent antibodies which can cause false positive cases in serological tests . Heifers were vaccinated using Brucella S19 vaccine at 5 months according to the compulsory vaccination protocol. It should be noted that no serological test gives an absolutely accurate result. Diagnosis should be based on two or more tests .
Other studies carried out on commercial dairy farms using RBT as a screening test and CFT or i-ELISA as confirmatory test, reported individual cow prevalence of 0.70–5.5% , 1.2% , 1.3% , 1.4% , 1.5% , 1.7%  and 1.9% . The low prevalence recorded in our study is in agreement with low prevalence recorded on commercial dairy farms in other countries.
The positive reactor, an 8 year old cow was culled as part of the national protocol for controlling brucellosis on dairy farms which is based on the test and slaughter policy. After culling the positive cow in 2013, the herd was free of the disease in 2014. However, for as long as the cow was in the herd, the risk of humans contracting brucellosis through raw milk was present. The absence of reactors in 2011 and 2012, suggests that the infection in the cow may have been a recent one or a false positive. However, this could also be a reflection of the lower and variable sensitivity of the RBT (63–99%) which missed the infection in 2011 and 2012 or the weakness of the test in detecting brucellosis in recently aborted cows or chronically infected cows [27, 28]. It has been reported that Brucella antibodies fluctuate in circulation at different phases of infection  and this can make it difficult to detect infected cows in low prevalence herds using tests with low sensitivity and specificity. The RBT and CFT tests used for serological screening and confirmation in this study are recognised tests for international trade purposes [12, 29], but the RBT has a low specificity in herds with a low brucellosis prevalence  as in the present study.
According to Matope et al.  and Mai et al. , effective measures for brucellosis control in bovines include quarantine and testing of new arrivals, calf hood vaccination, culling of positive reactors, controlled grazing, use of screened semen for insemination and the implementation of biosecurity measures. Dairy cows in our study were managed intensively under strict biosecurity protocols as described by Matope et al.  and Mai et al. . Therefore, the likelihood of introducing Brucella infections from outside the farm was low and this may explain the low serological prevalence recorded.
The low prevalence of brucellosis reported on the dairy farm confirms that the mandatory measures enforced by the state veterinary services to control the disease on the farm that are based on the test and slaughter approach were effective. The test-and-slaughter approach, as applied on the dairy farm, has been reported to be effective in herds with a low brucellosis prevalence [32, 33] as reported in our study. Based on the findings of this study, it can be concluded that the risk of animal handlers and consumers of raw milk contracting brucellosis from this farm is minimal, but cannot be excluded. It is therefore recommended that animal handlers be trained on the potential risk and that they put on the necessary personal protective clothing at all times when handling dairy cows. Consumers need to prioritise the boiling of raw milk before consumption or the consumption of pasteurised milk as a safe alternative because current serological tests are not absolute. The potential risk of zoonosis from dairy cows and fresh milk needs to be reflected in legislation and policy on occupational health and on trade in fresh milk in the country. The use of diagnostic tests with a higher specificity and sensitivity such as a Competitive ELISA (c-ELISA) is recommended in low prevalence herds is recommended. Results of this study are consistent with the fact that the farm had no clinical history of brucellosis as confirmed by records obtained from the regional state veterinary office.
The lack of information on age, parity and history of abortions precluded the assessment of risk factors for Brucella positivity. Due to the absence of records of replacement heifers, culled cows and the exact identity of animals tested for brucellosis annually, it was not possible to identify cows that were repeatedly tested over the study period.
The study was carried out on one commercial dairy farm.
The age and parity of individual cows was not available.
There were no records of abortions.
There were no records of the number of replacement heifers introduced and the number of cows culled and the reasons thereof.
Rose Bengal Test
Complement Fixation Test
Human Immunodeficiency Virus
World Organisation for Animal Health
Food and Agriculture Organisation
Competitive Enzyme Linked Immunosorbent Assay
Indirect Enzyme Linked Immunosorbent Assay
Mugizi DR, Boqvist S, Nasinyama GW, Waiswa C, Ikwap K, Rock K, Lindali E, Magnusson U, Frume J. Prevalence of the factors associated with Brucella sero-positivity in cattle in urban and peri-urban Gulu and Soroti towns of Uganda. J Vet Med Sci. 2015;77:557–64.
Mangen MJ, Otte J, Pfeiffer D, Chilonda P. Bovine brucellosis in sub-Saharan Africa: estimation of sero-prevalence and impact on meat and milk off-take potential. 2002. http://www.fao.org/3/a-ag274e.pdf. Accessed 5 Apr 2016.
Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a reemerging zoonosis. Vet Microbiol. 2010;140:392–8.
Godfroid J, Garin-Bastuji B, Blasco JM, Thomson J, Thoen CO. Brucella melitensis infection. In: Coetzer JAW, Thomson GR, Tustin RC, editors. Infectious diseases of livestock. Cape Town: Oxford University Press; 2004. p. 1535–41.
Godfroid J, Nielsen K, Saegerman C. Diagnosis of brucellosis in livestock and wildlife. Croat Med J. 2010;51:296–305.
Ibarra V, Blanco JR, Metola L, Oteo A. Relapsing brucellosis in a patient infected with the Immunodeficiency Virus (HIV). J Clin Microb Infect. 2003;9:12.
Magwedere K, Bishi A, Tjipura-Zaire G, Eberle G, Hemberger Y, Hoffman LC, Dziva F. Brucellae through the food chain: the role of sheep, goats and springbok (Antidorcus marsupialis) as sources of human infection in Namibia. J S Afr Vet Assoc. 2011;82:205–12.
Madzingira O, McCrindle CME. Prevalence of Brucella antibodies in sheep and springbok (Antidorcas marsupialis) reared together in the Karas region, Namibia. Bull Anim Health Prod Afr. 2014;62:299–306.
Madzingira O, McCrindle CME. Retrospective analysis of the prevalence of Brucella antibodies in sheep in the Karas Region of Namibia. Trop Anim Health Prod. 2015;47:1117.
Madzingira O, McCrindle CME. A questionnaire survey of risk factors of brucellosis on mixed sheep and springbok (Antidorcas marsupialis) farms. Int Sci Technol J Namibia. 2016;8:43–9.
Depner K. Brucellosis in domestic ruminants, game and man in Namibia: a serosurvey using different diagnostic methods. 1993. http://elib.tiho-hannover.de/dissertations/93depner-k.pdf. Accessed 20 June 2010.
Manual OIE. Manual of diagnostic tests and vaccines for terrestrial animals. Paris: Office International Des Epizooties; 2004.
Chisi SL, Marageni Y, Naidoo P, Zulu G, Akol GW, van Heerden H. An evaluation of serological tests in the diagnosis of bovine brucellosis in naturally infected cattle in KwaZulu-Natal province in South Africa. J S Afr Vet Assoc. 2017;88:a1381. https://doi.org/10.4102/jsava.v88i0.1381.
Reiczigel J, Földi J, Ózsvári L. Exact confidence limits for prevalence of a disease with an imperfect diagnostic test. Epid Infect. 2010;138:1674–8.
Bercovich Z. Maintenance of Brucella abortus free herds: a review with emphasis on epidemiology and the problems of diagnosing brucellosis in areas of low prevalence. Vet Quart. 1998;20:81–8.
Nielsen K, Smith P, Yu W, Nicoletti P, Jungersen G, Stack J, Godfroid J. Serological discrimination by enzyme immunoassay between the antibody response to Brucella sp. and Yersinia enterecolitica O:9 in cattle and pigs. Vet Immun Immunopathol. 2006;109:69–78.
Oie A. Manual of diagnostic tests and vaccines for terrestrial animals. Paris: Office international des epizooties; 2008. p. 1092–106.
FAO. Brucellosis in humans and animals. Rome: Food and Agriculture Organisation; 2006.
Rekha VB, Gunaseelan L, Subramanian A, Yale G. A study on bovine brucellosis in an organized dairy farm. Vet World. 2013;6:681–5.
Sacchia M, Di Provvido A, Ippoliti C, Kefle U, Sebhatu TTD, Angelo A, De Massis F. Prevalence of brucellosis in dairy farming regions of eritrea. Onderstepoort J Vet Res. 2013;80:4.
Abdullah AH, Bashir UM, Rafiqul IM, Cho H-S, Mukter HM. Serological prevalence of brucellosis of cattle in selected dairy farms in Bangladesh. Korean J Vet Res. 2014;54:239–43.
Asgedon H, Damena D, Duguma R. Seroprevalence of bovine brucellosis and associated risk factors in and around Alage district, Ethiopia. SpringerPlus. 2016;5:851. https://doi.org/10.1186/s40064-016-2547-0.
Geresu MA, Ameni G, Kassa T, Tuli G, Arenas A, Kassa GM. Seropositivity and risk factors for Brucella in dairy cows in Asella and Bishoftu towns, Oromia Regional State, Ethiopia. Afr J Microbiol Res. 2016;10:203–13.
Tesfaye G, Tsegaye W, Chanie M, Abinet F. Seroprevalence and associated risk factors of bovine brucellosis in Addis Ababa dairy farms. Trop Anim Health Prod. 2011;43:1001–5.
Tschopp R, Abera B, Sourou SY, Guerne-Bleich E, Aseffa A, Wubete A, Zinsstag J, Young D. Bovine tuberculosis and bruellosis prevalence in cattle from selected milk cooperatives in Arsi zone, Oromia region, Ethiopia. BMC Vet Res. 2013. https://doi.org/10.1186/1746-6148-9-163.
Asmare K, Sibhat B, Molla W, Ayelet G, Shiferaw J, Martin AD, Skjerve E, Godfroid J. The status of bovine brucellosis in Ethiopia with special emphasis on exotic and cross bred cattle in dairy and breeding farms. Acta Trop. 2013;126:186–92.
Bishop GC, Bosman PP, Herr S. Bovine brucellosis. In: Coetzer JAW, Thomson GR, Tustin RC, editors. Infectious diseases of livestock with special reference to Southern Africa. Cape Town: Oxford University Press; 1994. p. 1053–66.
Jeff A. Brucellosis diagnostics. Wyoming: Wyoming State University; 2003.
FAO. Brucella melitensis in Eurasia and the Middle East. Rome: FAO Animal Production and Health Proceedings. No. 10; 2010.
Matope G, Bhebhe E, Muma JB, Oloya J, Madekurozwa RL, Lund A, Skjerve E. Seroprevalence of brucellosis and its associated risk factors in cattle from small holder dairy farms in Zimbabwe. Trop Anim Health Prod. 2011;43:975–82.
Mai HM, Irons PC, Kabir J, Thompson PN. A large seroprevalence survey of brucellosis in cattle herds under diverse production systems in northern Nigeria. BMC Vet Res. 2012;8:144.
Nicoletti P. The eradication of brucellosis in animals. Saudi Med J. 1993;14:288–92.
FAO. Guidelines for coordinated animal and human brucellosis surveillance. Rome: FAO Animal Production and Health Paper 156; 2010.
OM and PMS were involved in research design, data collection and analysis. OM drafted the manuscript for publication and PMS reviewed the final draft. Both authors read and approved the final manuscript.
The authors are indebted to the dairy farm Herd Manager and the Directorate of Veterinary Services for making the data available for the study.
The authors declare that they have no competing interests.
Availability of data and materials
All data is presented in this manuscript.
Consent for publication
Ethics approval and consent to participate
Permission to access and use the data set was granted by the dairy farm Herd Manager.
This study was self-funded.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Madzingira, O., Sezuni, P.M. Serological prevalence and public health significance of brucellosis on a dairy farm in Namibia from 2011 to 2014. BMC Res Notes 10, 620 (2017). https://doi.org/10.1186/s13104-017-2933-x
- Public health